Nov 10 (Reuters) - Private equity firm GTCR can move

forward with its acquisition of medical device coatings maker

Surmodics' ( SRDX ), a federal judge in Chicago ruled on Monday,

rejecting the U.S. Federal Trade Commission's bid to block the

deal.

The FTC sued to block the deal in March in its first lawsuit

to block a merger during President Donald Trump's second term.